Dr. Morag Park is a Professor in the Departments of Medicine, Oncology, and Biochemistry at McGill University. She is a Fellow of the Royal Society of Canada, Fellow of the Canadian Academy of Health Sciences, James McGill Professor, and holds the Diane and Sal Guerrera Chair in Cancer Genetics. Dr. Park received a B.Sc. with first class honors from the University of Glasgow, a Ph.D. in Viral carcinogenesis at the Medical Research Council Virology Institute in Scotland, and completed postdoctoral training at the National Institutes for Cancer Research in Washington DC. She was the Director of the Molecular Oncology Group at the McGill University Hospital Centre (2006-8), Scientific Director of the Institute of Cancer Research - CIHR (2008-13), Canadian Cancer Research Alliance co-chair (2008-2010) and is Director of the Goodman Cancer Research Centre (2013-present). She is a research leader in the field of receptor tyrosine kinases (RTK) and mechanisms of oncogenic activation of RTKs in human cancers, has recently developed leadership in the breast cancer microenvironment, and is the recipient of the Canadian Cancer Research Alliance Award (2015), the Canadian Society for Molecular Biosciences Arthur Wynne Gold Medal Prize (2016), and the Canadian Cancer Society Robert L. Noble Prize (2017).